期刊文献+

2型糖尿病下肢血管病变患者血管新生相关因子的变化

Changes of angiogenesis-related factors in type 2 diabetic patients with lower extremity angiopathy
原文传递
导出
摘要 目的观察2型糖尿病(T2DM)下肢血管病变患者血管新生相关因子的变化,探讨血管新生在糖尿病下肢血管病变发展中的作用。方法测定31例T2DM无下肢血管病变患者(T2DM组)、49例T2DM下肢血管病变患者(下肢血管病变组)及40例正常对照者(对照组)血清CXCL16、碱性成纤维细胞生长因子(bFGF)、血小板源性内皮细胞生长因子(PD—ECGF)水平和外周血内皮祖细胞(EPCs)数量。应用多普勒超声测定踝臂指数(ABI),左、右足背动脉及左、右胭动脉内径,血流流速。结果T2DM组和对照组相比,血清bFGF、PD—ECGF水平升高(P均〈0.01),外周血EPCs数量下降(P〈0.001)。下肢血管病变组与T2DM组和对照组相比,血清CXCL16、bFGF、PD—ECGF水平升高(P均〈0.001),外周血EPCs数量下降(P〈0.01)。下肢血管病变组和T2DM组、对照组相比,ABI下降(P〈0.01),左、右足背动脉,左、右胭动脉内径减小(P〈0.01或P〈0.05),下肢血管病变组和对照组相比,左、右足背动脉,左、右胭动脉血流流速减低(P〈0.05)。结论T2DM下肢血管病变患者存在血管新生障碍,血管新生相关因子的升高和EPCs数量下降在糖尿病下肢血管病变发生中可能起重要作用。 Objective To investigate the changes of angiogenesis-related factors, and evaluate the effects of angiogenesis on lower extremity angiopathy in patients with type 2 diabetes mellitus (T2DM). Methods Serum levels of CXCL16, basic fibroblast growth factor (bFGF), platelet-derived endothelial cell growth factor (PD-ECGF) and the number of endothelial progenitor cells (EPCs) were examined in 31 T2DM patients without lower extremity angiopathy(T2DM group) ,49 T2DM patients with lower extremity an- giopathy(lower extremity angiopathy group), and 40 healthy controls( control group). Ankle brachial index (ABI) ,the inside diameter and blood velocity of arteria dorsalis pedis and arteria poplitea were measured with color Doppler uhrasonography. Results Serum levels of bFGF and PD-ECGF were significantly in- creased( P 〈 0.05 ) and the number of EPCs were significantly decreased (P 〈 0. 001 ) in T2DM group com- pared with those in control group. The serum levels of CXCL16, bFGF and PD-ECGF were significantly in- creased (P 〈 0.05 ) and the number of EPCs were significantly decreased (P 〈 0.01 ) in lower extremity angi- opathy group compared with those in T2DM group and in control group. ABI, the inside diameter of arteria dorsalis pedis and arteria poplitea were significantly decreased(P 〈 0.01 or P 〈 0.05 ) in lower extremity an- giopathy group compared with those in T2DM group and in control group. The blood velocity of arteria dorsalis pedis and arteria poplitea were significantly decreased(P 〈 0.05) in lower extremity angiopathy group compared with those in control group. Conclusions There was angiogenic impairment in patients with T2DM. Increased angiogenesis-related factors and decreased number of EPCs may play important roles in lower extremity angiopathy of T2DM.
出处 《国际内分泌代谢杂志》 北大核心 2012年第1期5-8,共4页 International Journal of Endocrinology and Metabolism
基金 天津市卫生局科技基金资助项目(07K132) 教育部留学回国人员科研启动基金
关键词 2型糖尿病 血管新生 CXCL16 踝臂指数 Type 2 diabetes mellitus Angiogenesis CXCL16 Ankle brachial index
  • 相关文献

参考文献2

二级参考文献60

  • 1Matloubian M,David A,Engel S,et al.A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo[J].Nat Immunol,2000,1(4):298-304.
  • 2Wilbanks A,Zondlo SC,Murphy K,et al.Expression cloning of the STRL33/BONZO/TYMSTRIigand reveals elements of CC,CXC,and CX3C chemokines[J].J Immunol,2001,166(8):5145-5154.
  • 3Shimaoka T,Kume N,Minami M,et al.Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein,SR-PSOX,on macrophages[J].J Biol Chem,2000,275(52):40663-40666.
  • 4Zhuge X,Murayama T,Arai H,et al.CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells[J].Biochem Biophys Res Commun,2005,331 (4):1295-1300.
  • 5Fukumoto N,Shimaoka T,Fujimura H,et al.Critical roles of CXC chemokine ligand 16/scavenger receptor that binds phesphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis[J].J Immunol,2004,173(3):1620-1627.
  • 6Yamauchi R,Tanaka M,Kume N,et al.Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+T cells in cardiac valves during inflammatory valvular heart disease[J].Arterioscler Thromb Vasc Biol,2004,24(2):282-287.
  • 7Bussolino F,Mantovani A,Persico G.Molecular mechanisms of blood vessel formation[J].Trends Biochem Sci,1997,22(7):251 -256.
  • 8Norrby K.In vivo models of angiogenesis[J].J Cell Mol Med,2006,10(3):588-612.
  • 9Hill JM,Zalos G,Halcox JP,et al.Circulating endothelial progenitor cells, vascular function, and cardiovascular riskNew England Journal of Medicine The,2003.
  • 10Tepper OM,Galiano RD,Capla JM,et al.Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structuresCirculation,2002.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部